{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:57:03Z","timestamp":1791255423918,"version":"4.1.0"},"reference-count":51,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Primary aldosteronism (PA) is the most common cause of endocrine arterial hypertension, and the suggested screening test for case detection is the aldosterone-to-renin ratio (ARR) or aldosterone-to-direct renin ratio (ADRR) based on radio-immunoassay (RIA) and chemiluminescence assay (CLIA), respectively. The objective of our study was to evaluate the reliability of CLIA for aldosterone and renin measurement and the diagnostic performance of ADRR. A prospective cohort of 1110 patients referred to a single laboratory medicine center underwent measurement of aldosterone and direct renin concentration (DRC) by CLIA and measurement of aldosterone and plasma renin activity (PRA) by RIA. Of 1110 patients, 640 obtained a final diagnosis of hypertension, and 90 of these patients were diagnosed with PA. Overall, between-method correlation was highly significant for aldosterone concentrations (R = 0.945, p &lt; 0.001) and less strong but significant for DRC\/PRA (R = 0.422, p &lt; 0.001). Among hypertensive patients, in PA cases, the areas under the receiver operator characteristics (ROC) curves were 0.928 (95% confidence interval 0.904\u20130.954) for ADRR and 0.943 (95% confidence interval 0.920\u20130.966) for ARR and were comparable and not significantly different. The highest accuracy was obtained with an ADRR cut-off of 25 (ng\/L)\/(mIU\/L), displaying a sensitivity of 91% and a specificity of 85%. The chemiluminescence assay for aldosterone and DRC is a reliable method for PA diagnosis compared to the classical RIA method.<\/jats:p>","DOI":"10.3390\/ijms25158453","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T13:14:42Z","timestamp":1722604482000},"page":"8453","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diagnostic Accuracy of Aldosterone and Renin Measurement by Chemiluminescence for Screening of Patients with Primary Aldosteronism"],"prefix":"10.3390","volume":"25","author":[{"given":"Martina","family":"Tetti","sequence":"first","affiliation":[{"name":"Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7884-7314","authenticated-orcid":false,"given":"Jacopo","family":"Burrello","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Goi","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6930-7073","authenticated-orcid":false,"given":"Mirko","family":"Parasiliti-Caprino","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8155-6098","authenticated-orcid":false,"given":"Giulia","family":"Gioiello","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Laboratory, Department of Laboratory Medicine, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Settanni","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Laboratory, Department of Laboratory Medicine, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-2005","authenticated-orcid":false,"given":"Silvia","family":"Monticone","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5480-1116","authenticated-orcid":false,"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-8369","authenticated-orcid":false,"given":"Giulio","family":"Mengozzi","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Laboratory, Department of Laboratory Medicine, University of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension","volume":"75","author":"Xu","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis","volume":"101","author":"Dekkers","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: A controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: A systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J. Hypertens."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41440-023-01538-x","article-title":"Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: A succinct review","volume":"47","author":"Wang","year":"2024","journal-title":"Hypertens. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: A retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: A position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J. Hypertens."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jfma.2023.08.021","article-title":"Who needs to be screened for primary aldosteronism?","volume":"123","author":"Huang","year":"2024","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: Practical clinical perspectives","volume":"285","year":"2019","journal-title":"J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.jfma.2023.05.021","article-title":"How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?","volume":"123","author":"Lu","year":"2024","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/HYPERTENSIONAHA.120.14871","article-title":"Effects of Ramipril on the Aldosterone\/Renin Ratio and the Aldosterone\/Angiotensin II Ratio in Patients with Primary Aldosteronism","volume":"76","author":"Guo","year":"2020","journal-title":"Hypertension"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1055\/s-0043-121468","article-title":"Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?","volume":"49","author":"Stowasser","year":"2017","journal-title":"Horm. Metab. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/clinem\/dgac460","article-title":"Approach to the Patient on Antihypertensive Therapy: Screen for Primary Aldosteronism","volume":"107","author":"Mulatero","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ejendo\/lvac002","article-title":"International multicenter survey on screening and confirmatory testing in primary aldosteronism","volume":"188","author":"Naruse","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ando.2016.02.003","article-title":"SFE\/SFHTA\/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps","volume":"77","author":"Douillard","year":"2016","journal-title":"Ann. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/jcem-31-5-507","article-title":"Measurement of aldosterone secretion rate by radio-immunoassay","volume":"31","author":"Bayard","year":"1970","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0001-2998(75)80033-X","article-title":"Radioimmunoassay of plasma renin activity","volume":"5","author":"Sealey","year":"1975","journal-title":"Semin. Nucl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/HJH.0b013e32833857ad","article-title":"European study group for the validation of DiaSorin LIAISON Direct Renin Assay. A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin","volume":"28","author":"Morganti","year":"2010","journal-title":"J. Hypertens."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2006.068502","article-title":"Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: Comparison to radioimmunoassays with and without extraction steps","volume":"52","author":"Schirpenbach","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability between Immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/HJH.0000000000001735","article-title":"Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration","volume":"36","author":"Baron","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/HJH.0b013e32833d2192","article-title":"The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma","volume":"28","author":"Rossi","year":"2010","journal-title":"J. Hypertens."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1258\/acb.2010.009230","article-title":"A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin","volume":"47","author":"Dorrian","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"ref_36","first-page":"115","article-title":"Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism","volume":"4","author":"Corbin","year":"2011","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/HJH.0000000000000076","article-title":"Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension","volume":"32","author":"Lonati","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1097\/HJH.0000000000000727","article-title":"Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays","volume":"33","author":"Manolopoulou","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","article-title":"Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism","volume":"34","author":"Burrello","year":"2016","journal-title":"J. Hypertens."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1515\/cclm-2015-1094","article-title":"Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension","volume":"54","author":"Rossi","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/jhh.2017.62","article-title":"Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up","volume":"31","author":"Pizzolo","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2195796","DOI":"10.1155\/2019\/2195796","article-title":"Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value","volume":"2019","author":"Li","year":"2019","journal-title":"Int. J. Hypertens."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinbiochem.2014.10.008","article-title":"Aldosterone determination: Comparison of a RIA assay and a CLIA assay","volume":"48","author":"Belaidi","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of Seated with Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1373\/clinchem.2008.116004","article-title":"Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry","volume":"55","author":"Taylor","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cca.2014.03.015","article-title":"Combination of LC-MS\/MS aldosterone and automated direct renin in screening for primary aldosteronism","volume":"433","author":"Juutilainen","year":"2014","journal-title":"Clin. Chim. Acta."},{"key":"ref_48","first-page":"1213","article-title":"Human prorenin: Pathophysiology and clinical implications","volume":"10","author":"Derkx","year":"1988","journal-title":"Clin. Exp. Hypertens. A"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jacc.2023.01.033","article-title":"Blood Levels of Angiotensinogen and Hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"81","author":"Trainor","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e1472","DOI":"10.1210\/clinem\/dgae057","article-title":"The Clinical Impact of Sample Storage at \u221220 \u00b0C on Renin Reference Intervals and Aldosterone-Renin Ratio Calculations","volume":"109","author":"Hillebrand","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1097\/HJH.0000000000002520","article-title":"Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: A position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J. Hypertens."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8453\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:28:59Z","timestamp":1760110139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":51,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25158453"],"URL":"https:\/\/doi.org\/10.3390\/ijms25158453","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}